MEDIOS AG (ILM1.DE) Stock Fundamental Analysis

FRA:ILM1 • DE000A1MMCC8

17 EUR
+0.22 (+1.31%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Taking everything into account, ILM1 scores 5 out of 10 in our fundamental rating. ILM1 was compared to 30 industry peers in the Health Care Providers & Services industry. While ILM1 has a great health rating, there are worries on its profitability. ILM1 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year ILM1 was profitable.
  • ILM1 had a positive operating cash flow in the past year.
  • ILM1 had positive earnings in each of the past 5 years.
  • ILM1 had a positive operating cash flow in 4 of the past 5 years.
ILM1.DE Yearly Net Income VS EBIT VS OCF VS FCFILM1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

  • With a Return On Assets value of 2.34%, ILM1 perfoms like the industry average, outperforming 46.88% of the companies in the same industry.
  • With a Return On Equity value of 4.25%, ILM1 is not doing good in the industry: 65.63% of the companies in the same industry are doing better.
  • With a Return On Invested Capital value of 3.73%, ILM1 is not doing good in the industry: 65.63% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for ILM1 is below the industry average of 6.83%.
  • The 3 year average ROIC (3.26%) for ILM1 is below the current ROIC(3.73%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.34%
ROE 4.25%
ROIC 3.73%
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ILM1.DE Yearly ROA, ROE, ROICILM1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • ILM1 has a Profit Margin of 1.09%. This is in the lower half of the industry: ILM1 underperforms 62.50% of its industry peers.
  • ILM1's Profit Margin has declined in the last couple of years.
  • ILM1 has a Operating Margin of 2.21%. This is amonst the worse of the industry: ILM1 underperforms 81.25% of its industry peers.
  • ILM1's Operating Margin has declined in the last couple of years.
  • ILM1 has a worse Gross Margin (9.66%) than 65.63% of its industry peers.
  • In the last couple of years the Gross Margin of ILM1 has grown nicely.
Industry RankSector Rank
OM 2.21%
PM (TTM) 1.09%
GM 9.66%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
ILM1.DE Yearly Profit, Operating, Gross MarginsILM1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • ILM1 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ILM1 has been increased compared to 1 year ago.
  • ILM1 has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ILM1 has a worse debt to assets ratio.
ILM1.DE Yearly Shares OutstandingILM1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ILM1.DE Yearly Total Debt VS Total AssetsILM1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • ILM1 has an Altman-Z score of 3.27. This indicates that ILM1 is financially healthy and has little risk of bankruptcy at the moment.
  • ILM1 has a Altman-Z score of 3.27. This is amongst the best in the industry. ILM1 outperforms 87.50% of its industry peers.
  • ILM1 has a debt to FCF ratio of 2.17. This is a good value and a sign of high solvency as ILM1 would need 2.17 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.17, ILM1 belongs to the top of the industry, outperforming 96.88% of the companies in the same industry.
  • A Debt/Equity ratio of 0.32 indicates that ILM1 is not too dependend on debt financing.
  • The Debt to Equity ratio of ILM1 (0.32) is better than 90.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 2.17
Altman-Z 3.27
ROIC/WACC0.55
WACC6.82%
ILM1.DE Yearly LT Debt VS Equity VS FCFILM1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 1.74 indicates that ILM1 should not have too much problems paying its short term obligations.
  • ILM1 has a Current ratio of 1.74. This is amongst the best in the industry. ILM1 outperforms 81.25% of its industry peers.
  • A Quick Ratio of 1.31 indicates that ILM1 should not have too much problems paying its short term obligations.
  • ILM1's Quick ratio of 1.31 is amongst the best of the industry. ILM1 outperforms 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.31
ILM1.DE Yearly Current Assets VS Current LiabilitesILM1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 63.63% over the past year.
  • Measured over the past years, ILM1 shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.00% on average per year.
  • Looking at the last year, ILM1 shows a quite strong growth in Revenue. The Revenue has grown by 9.27% in the last year.
  • The Revenue has been growing by 29.51% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)63.63%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%80.36%
Revenue 1Y (TTM)9.27%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%9.13%

3.2 Future

  • The Earnings Per Share is expected to grow by 19.17% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 2.79% on average over the next years.
EPS Next Y5.3%
EPS Next 2Y17.64%
EPS Next 3Y19.17%
EPS Next 5YN/A
Revenue Next Year8.39%
Revenue Next 2Y6.17%
Revenue Next 3Y5.58%
Revenue Next 5Y2.79%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ILM1.DE Yearly Revenue VS EstimatesILM1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
ILM1.DE Yearly EPS VS EstimatesILM1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • ILM1 is valuated rather expensively with a Price/Earnings ratio of 19.54.
  • The rest of the industry has a similar Price/Earnings ratio as ILM1.
  • Compared to an average S&P500 Price/Earnings ratio of 27.07, ILM1 is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 12.15 indicates a correct valuation of ILM1.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ILM1 indicates a rather cheap valuation: ILM1 is cheaper than 81.25% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of ILM1 to the average of the S&P500 Index (28.05), we can say ILM1 is valued rather cheaply.
Industry RankSector Rank
PE 19.54
Fwd PE 12.15
ILM1.DE Price Earnings VS Forward Price EarningsILM1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ILM1 is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
  • 84.38% of the companies in the same industry are more expensive than ILM1, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.75
EV/EBITDA 6.52
ILM1.DE Per share dataILM1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ILM1's earnings are expected to grow with 19.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.69
PEG (5Y)N/A
EPS Next 2Y17.64%
EPS Next 3Y19.17%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ILM1 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MEDIOS AG

FRA:ILM1 (2/27/2026, 7:00:00 PM)

17

+0.22 (+1.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-11
Earnings (Next)03-26
Inst Owners39.25%
Inst Owner ChangeN/A
Ins Owners19.7%
Ins Owner ChangeN/A
Market Cap433.67M
Revenue(TTM)2.01B
Net Income(TTM)22.03M
Analysts87.27
Price Target24.48 (44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)1.08%
Valuation
Industry RankSector Rank
PE 19.54
Fwd PE 12.15
P/S 0.22
P/FCF 4.75
P/OCF 4.39
P/B 0.84
P/tB 15.78
EV/EBITDA 6.52
EPS(TTM)0.87
EY5.12%
EPS(NY)1.4
Fwd EY8.23%
FCF(TTM)3.58
FCFY21.05%
OCF(TTM)3.87
OCFY22.77%
SpS78.89
BVpS20.31
TBVpS1.08
PEG (NY)3.69
PEG (5Y)N/A
Graham Number19.94
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 4.25%
ROCE 6.15%
ROIC 3.73%
ROICexc 4.29%
ROICexgc 19.24%
OM 2.21%
PM (TTM) 1.09%
GM 9.66%
FCFM 4.54%
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ROICexc(3y)3.82%
ROICexc(5y)3.8%
ROICexgc(3y)12.89%
ROICexgc(5y)11.48%
ROCE(3y)5.38%
ROCE(5y)5.1%
ROICexgc growth 3Y-0.85%
ROICexgc growth 5Y-8.22%
ROICexc growth 3Y-6.07%
ROICexc growth 5Y-23.77%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
F-Score7
Asset Turnover2.14
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 2.17
Debt/EBITDA 2.04
Cap/Depr 19.67%
Cap/Sales 0.37%
Interest Coverage 3.48
Cash Conversion 119.67%
Profit Quality 414.43%
Current Ratio 1.74
Quick Ratio 1.31
Altman-Z 3.27
F-Score7
WACC6.82%
ROIC/WACC0.55
Cap/Depr(3y)16.31%
Cap/Depr(5y)50.4%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.49%
Profit Quality(3y)264.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.63%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%80.36%
EPS Next Y5.3%
EPS Next 2Y17.64%
EPS Next 3Y19.17%
EPS Next 5YN/A
Revenue 1Y (TTM)9.27%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%9.13%
Revenue Next Year8.39%
Revenue Next 2Y6.17%
Revenue Next 3Y5.58%
Revenue Next 5Y2.79%
EBIT growth 1Y59.29%
EBIT growth 3Y27.64%
EBIT growth 5Y18.54%
EBIT Next Year99.49%
EBIT Next 3Y34.03%
EBIT Next 5Y29.68%
FCF growth 1Y229.48%
FCF growth 3Y11.42%
FCF growth 5YN/A
OCF growth 1Y228.59%
OCF growth 3Y6.19%
OCF growth 5YN/A

MEDIOS AG / ILM1.DE FAQ

What is the fundamental rating for ILM1 stock?

ChartMill assigns a fundamental rating of 5 / 10 to ILM1.DE.


What is the valuation status of MEDIOS AG (ILM1.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to MEDIOS AG (ILM1.DE). This can be considered as Fairly Valued.


How profitable is MEDIOS AG (ILM1.DE) stock?

MEDIOS AG (ILM1.DE) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for ILM1 stock?

The Earnings per Share (EPS) of MEDIOS AG (ILM1.DE) is expected to grow by 5.3% in the next year.


How sustainable is the dividend of MEDIOS AG (ILM1.DE) stock?

The dividend rating of MEDIOS AG (ILM1.DE) is 0 / 10 and the dividend payout ratio is 0%.